Detailed description page of B3Pdb
This page provides detail information of Selected ID b3pdb_1221 |
| Primary information | |
|---|---|
| B3PDB ID | b3pdb_1221 |
| Peptide Name | MKP |
| PEPTIDE SEQUENCE (1-letter) | MKP |
| PEPTIDE SEQUENCE (3-letter) | Met-Lys-Pro |
| N-terminal modification | NA |
| C-terminal modification | NA |
| Chemical modification | NA |
| Peptide Length | 3 |
| Conformation | Linear |
| Peptide Nature | NA |
| Source/Origin of peptide | Casein |
| SMILES | NA |
| Cell Line | NA |
| In vitro CONCENTRATION | NA |
| In vitro METHOD | NA |
| In vitro RESULT | NA |
| ANIMAL MODEL | Human |
| In vivo CONCENTRATION | 50 μg |
| In vivo MODE OF DELIVERY | Oral |
| In vivo METHOD | Alzheimer’s Disease Assessment Scale |
| In vivo RESULT | It is casein- derived angiotensin-converting enzyme inhibitory peptide with the potential to cross t |
| ACTION | The safety of daily MKP intake and its potential to improve orientation in adults without dementia. |
| TRANSPORT TYPE | NA |
| SUBCELLULAR LOCALISATION | NA |
| COMBINATION | NA |
| PHYSICAL CONDITION | NA |
| RESPONSE | NA |
| RESULT | NA |
| LABEL | NA |
| PMID | 32546992 |